Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03073343 · ClinicalTrials.gov registry record · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
A NA study of Non-alcoholic Fatty Liver Disease and Non Insulin Dependent Diabetes, sponsored by Southern California Institute for Research and Education.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT03073343: Recruiting NA study of Non-alcoholic Fatty Liver Disease and Non Insulin Dependent Diabetes, sponsored by Southern California Institute for Research and Education.
NCT03073343 is a NA study of Non-alcoholic Fatty Liver Disease and Non Insulin Dependent Diabetes that is actively recruiting participants, run by Southern California Institute for Research and Education. The registered enrollment target is 48 participants, below the 176-participant average among 57 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03073343, a NA study of Non-alcoholic Fatty Liver Disease and Non Insulin Dependent Diabetes, is actively recruiting participants, sponsored by Southern California Institute for Research and Education.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
Betaine (trimethyglycine) is a food supplement that is approved for sale in the United States without a prescription. In this study, betaine will be provided to patients as a powder that can be mixed with aqueous solutions and consumed orally.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Betaine (trimethyglycine)
Study Locations (1)
California
- VA Long Beach Healthcare System - Long Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2013-11-12 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
What NCT03073343 shows while recruiting
NCT03073343 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 176-participant average among 57 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (73% lower).
The record links to 3 conditions, with Non-alcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 1 intervention - of which Betaine (trimethyglycine) is the first listed.
NCT03073343 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03073343 about?
NCT03073343 is a clinical study titled "A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine". Betaine (trimethyglycine) is a food supplement that is approved for sale in the United States without a prescription. In this study, betaine will be provided to patients as a powder that can be mixed with aqueous solutions and consumed orally.
What is the current status of trial NCT03073343?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2013-11-12. Estimated completion is 2025-12-30.
What conditions does trial NCT03073343 study?
This clinical trial studies the following conditions: Non-alcoholic Fatty Liver Disease, Non Insulin Dependent Diabetes, ALT.
What interventions are being tested in trial NCT03073343?
The interventions under investigation include: Betaine (trimethyglycine) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03073343?
This trial is sponsored by Southern California Institute for Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03073343 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-alcoholic Fatty Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03073343's enrollment target sits among peer trials
48 35th of 57 higher than 22 of 57 other Non-alcoholic Fatty Liver Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Non-alcoholic Fatty Liver Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intermittent Fasting for NAFLD in Adults
RECRUITING · NA
-
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents
RECRUITING · NA
-
The Olmsted NAFLD Epidemiology Study (TONES)
RECRUITING · NA
-
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
RECRUITING · NA
-
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
ACTIVE NOT RECRUITING · NA
-
Prevention of NAFLD in Hispanic Children
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
- NCT03579875 · 48 participants · Phase 2
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI